Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
AstraZeneca
Julphar
McKinsey
QuintilesIMS
Deloitte
Cipla
Express Scripts
Medtronic

Generated: May 28, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021481

« Back to Dashboard

NDA 021481 describes FUZEON, which is a drug marketed by Roche and is included in one NDA. It is available from one supplier. Additional details are available on the FUZEON profile page.

The generic ingredient in FUZEON is enfuvirtide. One supplier is listed for this compound. Additional details are available on the enfuvirtide profile page.
Summary for 021481
Tradename:FUZEON
Applicant:Roche
Ingredient:enfuvirtide
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021481
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FUZEON enfuvirtide INJECTABLE;SUBCUTANEOUS 021481 NDA Genentech, Inc. 0004-0381 N 0004-0381-40

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength90MG/VIAL
Approval Date:Mar 13, 2003TE:RLD:Yes

Expired US Patents for NDA 021481

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche FUZEON enfuvirtide INJECTABLE;SUBCUTANEOUS 021481-001 Mar 13, 2003 ➤ Sign Up ➤ Sign Up
Roche FUZEON enfuvirtide INJECTABLE;SUBCUTANEOUS 021481-001 Mar 13, 2003 ➤ Sign Up ➤ Sign Up
Roche FUZEON enfuvirtide INJECTABLE;SUBCUTANEOUS 021481-001 Mar 13, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Colorcon
Fuji
Cipla
Harvard Business School
Express Scripts
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.